Literature DB >> 26753010

Myeloid Proliferations Associated with Down Syndrome.

Alan B Cantor1.   

Abstract

Entities:  

Year:  2014        PMID： 26753010      PMCID： PMC4704699          DOI： 10.1007/s12308-014-0225-0

Source DB:  PubMed          Journal:  J Hematop        ISSN： 1865-5785            Impact factor:   0.196


× No keyword cloud information.
  61 in total

1.  Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome.

Authors:  Jeffrey W Taub; Gina Mundschau; Yubin Ge; Janet M Poulik; Faisal Qureshi; Tanya Jensen; S Jill James; Larry H Matherly; Joshua Wechsler; John D Crispino
Journal:  Blood       Date:  2004-09-01       Impact factor: 22.113

2.  High frequency of copy number alterations in myeloid leukaemia of Down syndrome.

Authors:  Marjolein Blink; Marry M van den Heuvel-Eibrink; Anna M Aalbers; Brian V Balgobind; Iris H I M Hollink; Jules P P Meijerink; Vincent H J van der Velden; Berna H Beverloo; Valerie de Haas; Henrik Hasle; Dirk Reinhardt; Jan-Henning Klusmann; Rob Pieters; Rodrigo T Calado; Christian M Zwaan
Journal:  Br J Haematol       Date:  2012-07-07       Impact factor: 6.998

3.  Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1.

Authors:  Y Fujiwara; C P Browne; K Cunniff; S C Goff; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

4.  GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.

Authors:  Johann K Hitzler; Joseph Cheung; Yue Li; Stephen W Scherer; Alvin Zipursky
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

Review 5.  Origins of leukaemia in children with Down syndrome.

Authors:  Johann K Hitzler; Alvin Zipursky
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

Review 6.  Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.

Authors:  Sandeep Gurbuxani; Paresh Vyas; John D Crispino
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

7.  Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.

Authors:  Oliver Tunstall-Pedoe; Anindita Roy; Anastasios Karadimitris; Josu de la Fuente; Nicholas M Fisk; Phillip Bennett; Alice Norton; Paresh Vyas; Irene Roberts
Journal:  Blood       Date:  2008-08-08       Impact factor: 22.113

8.  Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.

Authors:  Gina Kirsammer; Sarah Jilani; Hui Liu; Elizabeth Davis; Sandeep Gurbuxani; Michelle M Le Beau; John D Crispino
Journal:  Blood       Date:  2007-09-27       Impact factor: 22.113

9.  Altered translation of GATA1 in Diamond-Blackfan anemia.

Authors:  Leif S Ludwig; Hanna T Gazda; Jennifer C Eng; Stephen W Eichhorn; Prathapan Thiru; Roxanne Ghazvinian; Tracy I George; Jason R Gotlib; Alan H Beggs; Colin A Sieff; Harvey F Lodish; Eric S Lander; Vijay G Sankaran
Journal:  Nat Med       Date:  2014-06-22       Impact factor: 53.440

10.  AKT collaborates with ERG and Gata1s to dysregulate megakaryopoiesis and promote AMKL.

Authors:  M J Stankiewicz; J D Crispino
Journal:  Leukemia       Date:  2013-02-05       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.